0000000000718535

AUTHOR

Mehmet Yilmaz

showing 2 related works from this author

Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis

2017

WOS: 000458034100002

medicine.medical_specialtybusiness.industryCancerAtrial fibrillation030204 cardiovascular system & hematologymedicine.diseaseMean differenceCancer antigen03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisMeta-analysisInternal medicineJournal ArticleMedicineSinus rhythmIn patientCardiology and Cardiovascular MedicineProspective cohort studybusinessOriginal ResearchHeart Asia
researchProduct

Worldwide experience of homozygous familial hypercholesterolaemia:retrospective cohort study

2022

[Background]: Homozygous familial hypercholesterolaemia (HoFH) is a rare inherited disorder resulting in extremely elevated low-density lipoprotein cholesterol levels and premature atherosclerotic cardiovascular disease (ASCVD). Current guidance about its management and prognosis stems from small studies, mostly from high-income countries. The objective of this study was to assess the clinical and genetic characteristics, as well as the impact, of current practice on health outcomes of HoFH patients globally.

AdultMaleHomozygous Familial HypercholesterolemiaAdolescentretrospective studyCHILDRENDoenças Cardio e Cérebro-vascularesCohort StudiesYoung AdultMedicine General & InternalGeneral & Internal MedicineCardiovascular DiseaseHumansRegistriesLIPOPROTEIN-APHERESISChild11 Medical and Health SciencesRetrospective StudiesHomozygous Familial Hypercholesterolaemia International Clinical CollaboratorsScience & TechnologyGUIDANCEclinical characteristicEVOLOCUMABHomozygous familial hypercholesterolemia; Worldwide; Therapies; Cardiovascular diseaseGeneral MedicineCARECardiovascular diseaseOPEN-LABELEFFICACYINSIGHTSTherapiesChild PreschooloutcomeFemalegeneticFamilial HypercholesterolaemiaLife Sciences & BiomedicineWorldwide
researchProduct